The Global Prefilled Syringes Drug Molecules Industry is on an upward trajectory, poised to achieve a significant milestone in 2028. Projections indicate that the industry, valued at US$ 56 billion in 2022, is set to grow at a steady CAGR of 5.6%, reaching an impressive US$ 77.7 billion by 2028.
Prefilled syringes, prefilled with medication by manufacturers and supplied to end users in ready-to-use form, are playing a pivotal role in this growth. The healthcare landscape has witnessed a notable increase in global investments in recent years, with a growing demand for solutions that enhance the quality of life. This surge presents substantial opportunities for pharmaceutical companies, contributing significantly to the expansion of various healthcare industry segments, including the Global Prefilled Syringes Drug Molecules Industry.
A recently released research report by Future Market Insights, titled ‘Global Prefilled Syringes Drug Molecules Industry: Analysis 2012–2021 and Opportunity Assessment 2022-2028,’ sheds light on the current scenario and future prospects of the Global Prefilled Syringes Drug Molecules Industry. According to the market analysis, the industry is poised to achieve a market valuation of over US$ 70 billion by the end of 2027, showcasing a commendable CAGR of 5.7% throughout the forecast period.
Claim your complimentary report with captivating visuals.
https://www.futuremarketinsights.com/reports/sample/rep-gb-3198
Global Prefilled Syringes Drug Molecules Industry: Drivers and Opportunities
The report indicates that the revenue growth of the market is mainly driven by the effectiveness, convenience, and ease of use of prefilled syringes. This has attracted various healthcare professionals and patients to use prefilled syringes. In addition, the minimal contamination of drug molecules and self-administration of drugs at home settings has increased the demand for prefilled syringe drug molecules. Manufacturers are focussing on introducing updated technologies and advanced products to attract customers. Pharmaceutical companies are introducing generic versions of cost-effective auto-injector devices. They are targeting emerging regions such as the Asia Pacific, the Middle East, and others to sustain and grow in the Global Prefilled Syringes Drug Molecules Industry.
Global Prefilled Syringes Drug Molecules Industry: Segmental Analysis
- Based on region, North America is expected to lead the market with a huge margin. The North American prefilled syringes drug molecules market is expected to reach a market valuation of over US$ 23,000 Mn by the end of 2028, growing at a CAGR of 6.2% during the forecast period.
- Based on drug class, vaccines, and insulin are anticipated to show quite a similar forecast with a high revenue share and CAGR
- Based on application, immunization dominates the Global Prefilled Syringes Drug Molecules Industry with its projected revenue share. However, diabetes leads in terms of growth rate with a 6.6% CAGR during the forecast period.
- In terms of end users, hospital pharmacies are expected to lead the global market with a market revenue of over US$ 32,000 Mn by 2028. However, online pharmacies are projected to register a higher growth rate of 6.2% during the forecast period.
Request Research Methodology Instantly!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-3198
Global Prefilled Syringes Drug Molecules Industry: Competitive Landscape
This comprehensive research report consists of a brief profile of all the major players in the industry. Some of the top companies featured in the report are Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Pfizer, Inc., Fresenius Kabi AG, Johnson & Johnson, Sanofi, Merck & Co. Inc., Novartis AG, etc. The Global Prefilled Syringes Drug Molecules Industry is highly competitive due to the presence of well-established top players. However, brands such as EpiPen auto-injector and BD Physioject disposable auto-injector have strategically maintained their position in the market owing to a distinctive value proposition such as providing more precision and accurate dosage.
Key Segments of Global Prefilled Syringes Drug Molecules Industry Research by Drug Class:
- Vaccines
- Insulin
- Adrenaline
- Opioids
- Others
By Application:
- Prefilled Syringes Drug Molecules for Cardiovascular Diseases
- Prefilled Syringes Drug Molecules for Diabetes
- Prefilled Syringes Drug Molecules for Immunization
- Prefilled Syringes Drug Molecules for Pain Management
- Others
By End User:
- Prefilled Syringes Drug Molecules Sold at Hospital Pharmacies
- Prefilled Syringes Drug Molecules Sold at Retail Pharmacies
- Prefilled Syringes Drug Molecules Sold through Online Pharmacies
- Prefilled Syringes Drug Molecules Sold at Drug Stores
Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/3198
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube